Pals-associated tight junction protein functionally links dopamine and angiotensin II to the regulation of sodium transport in renal epithelial cells.
OBJECTIVE
Dopamine inhibits renal cell Na(+),K(+)-ATPase activity and cell sodium transport by promoting the internalization of active molecules from the plasma membrane, whereas angiotensin II (ATII) stimulates its activity by recruiting new molecules to the plasma membrane. They achieve such effects by activating multiple and distinct signalling molecules in a hierarchical manner. The purpose of this study was to investigate whether dopamine and ATII utilize scaffold organizer proteins as components of their signalling networks, in order to avoid deleterious cross talk.


METHODS
Attention was focused on a multiple PDZ domain protein, Pals-associated tight junction protein (PATJ). Ectopic expression of PATJ in renal epithelial cells in culture was used to study its interaction with components of the dopamine signalling cascade. Similarly, expression of PATJ deletion mutants was employed to analyse its functional relevance during dopamine-, ATII- and insulin-dependent regulation of Na(+),K(+)-ATPase.


RESULTS
Dopamine receptors and components of its signalling cascade mediating inhibition of Na(+),K(+)-ATPase interact with PATJ. Inhibition of Na(+),K(+)-ATPase by dopamine was prevented by expression of mutants of PATJ lacking PDZ domains 2, 4 or 5; whereas the stimulatory effect of ATII and insulin on Na(+),K(+)-ATPase was blocked by expression of PATJ lacking PDZ domains 1, 4 or 5.


CONCLUSIONS
A multiple PDZ domain protein may add functionality to G protein-coupled and tyrosine kinase receptors signalling during regulation of Na(+),K(+)-ATPase. Signalling molecules and effectors can be integrated into a functional network by the scaffold organizer protein PATJ via its multiple PDZ domains.
Chen
Z
Z
Department of Medicine, Karolinska Institutet, Karolinska University Hospital-Solna, Stockholm, Sweden.
Leibiger
I
I
Katz
A I
AI
Bertorello
A M
AM
D000804:Angiotensin II / Q000378:metabolism*; D000818:Animals; D001692:Biological Transport; D002460:Cell Line; D004298:Dopamine / Q000378:metabolism*; D004847:Epithelial Cells / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000166:cytology / Q000378:metabolism; D008565:Membrane Proteins / Q000502:physiology*; D009893:Opossums; D054731:PDZ Domains; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism; D011954:Receptors, Dopamine / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism; D015398:Signal Transduction; D012964:Sodium / Q000378:metabolism*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D062725:Tight Junction Proteins
D008565:Membrane Proteins; C107903:PATJ protein, human; D011954:Receptors, Dopamine; D043562:Receptors, G-Protein-Coupled; D062725:Tight Junction Proteins; D000804:Angiotensin II; D012964:Sodium; D020794:Receptor Protein-Tyrosine Kinases; D000254:Sodium-Potassium-Exchanging ATPase; D004298:Dopamine